phase readout
saveNCT06815627: Safety and Efficacy Evaluation of NH002 as a Contrast Agent in Subjects Undergoing Cardiac Echocardiography
ACTIVE_NOT_RECRUITINGupdated 10m ago
community read0 votes
Sponsor: Trust Bio-sonics, Inc.. Phase: PHASE3. Conditions: Cardiac Diseases
view source ↗
comments(0)
5-min edit window · permanent after that